Type 2 Diabetes (Oral Therapy)# Recommendation : Orforglipron Reason : ACHIEVE-3 directly demonstrated orforglipron 36 mg superiority over oral semaglutide 14 mg for HbA1c reduction (2.2% vs 1.4%) and weight loss (9.2% vs 5.3%) in type 2 diabetes
This product is designed for general wellness use and is not intended to diagnose, treat, cure, or prevent any disease.
A cohort study with 193,676 participants further revealed that higher nondairy animal protein consumption results in a disturbance of uric acid metabolism, including a reduced level of citrate and a higher level of uric acid and acidic urine, which subsequently promotes uric acid stone formation [94]
Maintain adequate hydration when using the supplement
Why Some Semaglutide Patients Report Throat Discomfort Nausea and reduced appetite from semaglutide can lead to dry mouth and less frequent swallowing, which may create a scratchy or uncomfortable throat sensation
Also, a manufacturers use of the term standardized (or verified or certified) does not necessarily guarantee product quality or consistency